CITIC Capital Holdings
VC Fund
Central, Hong Kong
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
- Total investments:
- 107
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $2.8B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CITIC Capital Holdings invests in
Stages CITIC Capital Holdings invests in
Countries CITIC Capital Holdings invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $3.2M–$230M
- Series B
- $7.2M–$50M
- Series C
- $10M–$220M
Investment Focus
Industry
- Manufacturing 17 (16%)
- Health Care 11 (10%)
- Biotechnology 11 (10%)
- Medical 10 (9%)
- E-Commerce 9 (8%)
Stage
- Series A 25 (23%)
- Series B 21 (20%)
- Series C 12 (11%)
- Series D 10 (9%)
- Venture - Series Unknown 10 (9%)
Country
- China 73 (68%)
- United States 7 (7%)
- Japan 4 (4%)
- Hong Kong 3 (3%)
- Singapore 2 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Zhang Yichen
Founder, Chief Executive Officer
|
Founder, Chief Executive Officer | Total investments: 5 | Find email | |
Alice Zhang
Senior Associate
|
Senior Associate | Total investments: 0 | Find email | |
|
Lei Zhao
Senior Managing Director
|
Senior Managing Director | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology. | $3.3M / Series F / Oct 01, 2026 | ||
| Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China. | Series C / Sep 15, 2026 | ||
| Xuntu Technology is a leading data intelligence provider specializing in investment research and decision-making solutions. | $44.7M / Series B / Sep 10, 2026 | ||
| Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies. | $14.8M / Series A / Jul 30, 2026 | ||
| Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc. | $600M / Series D / Oct 23, 2025 | ||
| Healthy Tree is a comprehensive solution provider for self-medication devices. | Series B / Mar 04, 2025 | ||
| Regional Fish provides seed, seedlings, aquaculture methods and fisheries services. | $19.1M / Series C / Dec 26, 2024 | ||
| Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules. | Secondary Market / Jul 11, 2024 | ||
| Yitong Technology is an AI integrated platform and intelligent data processing solution provider of no-code modeling automated model. | $14.2M / Series A / Sep 20, 2023 | ||
| ATG Biotechnology engages in the R&D, production and application enzyme preparations. | Series A / May 22, 2023 | ||
| See all 107 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CITIC Capital Holdings invest in?
CITIC Capital Holdings invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 107 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does CITIC Capital Holdings invest in?
CITIC Capital Holdings typically joins rounds of $3.2M–$230M at Series A, $7.2M–$50M at Series B and $10M–$220M at Series C. These are whole funding-round sizes, not CITIC Capital Holdings's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds CITIC Capital Holdings took part in.
How do I contact CITIC Capital Holdings?
Public channels for CITIC Capital Holdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CITIC Capital Holdings?
The team at CITIC Capital Holdings includes Zhang Yichen (Founder, Chief Executive Officer), Alice Zhang (Senior Associate) and Lei Zhao (Senior Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
